Impact of human immunodeficiency virus type 1 gp41 amino acid substitutions selected during enfuvirtide treatment on gp41 binding and antiviral potency of enfuvirtide in vitro (Q33984351)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Impact of human immunodeficiency virus type 1 gp41 amino acid substitutions selected during enfuvirtide treatment on gp41 binding and antiviral potency of enfuvirtide in vitro |
scientific article |
Statements
1 reference
Impact of human immunodeficiency virus type 1 gp41 amino acid substitutions selected during enfuvirtide treatment on gp41 binding and antiviral potency of enfuvirtide in vitro (English)
1 reference
M Mink
1 reference
S M Mosier
1 reference
S Janumpalli
1 reference
D Davison
1 reference
L Jin
1 reference
T Melby
1 reference
P Sista
1 reference
J Erickson
1 reference
D Lambert
1 reference
S A Stanfield-Oakley
1 reference
M Salgo
1 reference
N Cammack
1 reference
T Matthews
1 reference
M L Greenberg
1 reference
1 October 2005
1 reference
1 reference
79
1 reference
19
1 reference
12447-12454
1 reference
Identifiers
1 reference
1 reference
1 reference